(R),(R',S')-2-[3-(α-methylbenzyl)phenyl]propionyl chloride | 454701-83-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (R),(R',S')-2-[3-(α-methylbenzyl)phenyl]propionyl chloride
• CAS: 454701-83-8
• 化学式: C₁₇H₁₇ClO
• 分子量: 272.774
• InChiKey: SLWDUICZGNDKTP-ZGTCLIOFSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.71
• 重原子数：
  19.0
• 可旋转键数：
  4.0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.24
• 拓扑面积：
  17.07
• 氢给体数：
  0.0
• 氢受体数：
  1.0

反应信息

• 作为反应物：
  描述：

  (R),(R',S')-2-[3-(α-methylbenzyl)phenyl]propionyl chloride 、 N,N-二甲基-1,3-二氨基丙烷 在 三乙胺 作用下， 以 二氯甲烷 为溶剂， 反应 4.0h， 以46 mg的产率得到(R),(R',S')-2-[3'-(α-methylbenzyl)phenyl]-N-[3-(dimethylamino)propyl]propionamide
  参考文献：
  名称：

  2-Arylpropionic CXC Chemokine Receptor 1 (CXCR1) Ligands as Novel Noncompetitive CXCL8 Inhibitors

  摘要：

  The CXC chemokine CXCL8/IL-8 plays a major role in the activation and recruitment of polymorphonuclear (PMN) cells at inflammatory sites. CXCL8 activates PMNs by binding the seven-transmembrane (7-TM) G-protein-coupled receptors CXC chemokine receptor 1 (CXCR1) and CXC chemokine receptor 2 (CXCR2). (R)-Ketoprofen (1) was previously reported to be a potent and specific noncompetitive inhibitor of CXCL8-induced human PMNS chemotaxis. We report here molecular modeling studies showing a putative interaction site of 1 in the TM region of CXCR1. The binding model was confirmed by alanine scanning mutagenesis and photoaffinity labeling experiments. The molecular model driven medicinal chemistry optimization of 1 led to a new class of potent and specific inhibitors of CXCL8 biological activity. Among these, repertaxin (13) was selected as a clinical candidate drug for prevention of post-ischemia reperfusion injury.

  DOI：

  10.1021/jm049082i
• 作为产物：
  描述：

  (2R)-2-(3-苯甲酰基苯基)丙酸 在 palladium on activated charcoal 氢氧化钾 、 正丁基锂 、 氯化亚砜 、 硫酸 、 氢气 作用下， 以 四氢呋喃 、 1,4-二氧六环 、 乙醇 、 正己烷 为溶剂， 反应 29.0h， 生成 (R),(R',S')-2-[3-(α-methylbenzyl)phenyl]propionyl chloride
  参考文献：
  名称：

  2-Arylpropionic CXC Chemokine Receptor 1 (CXCR1) Ligands as Novel Noncompetitive CXCL8 Inhibitors

  摘要：

  The CXC chemokine CXCL8/IL-8 plays a major role in the activation and recruitment of polymorphonuclear (PMN) cells at inflammatory sites. CXCL8 activates PMNs by binding the seven-transmembrane (7-TM) G-protein-coupled receptors CXC chemokine receptor 1 (CXCR1) and CXC chemokine receptor 2 (CXCR2). (R)-Ketoprofen (1) was previously reported to be a potent and specific noncompetitive inhibitor of CXCL8-induced human PMNS chemotaxis. We report here molecular modeling studies showing a putative interaction site of 1 in the TM region of CXCR1. The binding model was confirmed by alanine scanning mutagenesis and photoaffinity labeling experiments. The molecular model driven medicinal chemistry optimization of 1 led to a new class of potent and specific inhibitors of CXCL8 biological activity. Among these, repertaxin (13) was selected as a clinical candidate drug for prevention of post-ischemia reperfusion injury.

  DOI：

  10.1021/jm049082i

文献信息

• OMEGA-AMINOALKYLAMIDES OF (R)-2-ARYL-PROPIONIC ACIDS AS INHIBITORS OF THE CHEMOTAXIS OF POLYMORPHONUCLEATE AND MONONUCLEATE CELLS
  申请人：Dompé farmaceutici s.p.a.

  公开号：EP1366018B1

  公开（公告）日：2016-07-06